Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS ...
Exl-111 is an investigational allergic Effector Cell Response Inhibitor (ECRI) targeting the IgE axis and is designed to disarm allergic ...
LOS ANGELES, Feb. 27, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded ...
Spina bifida is a type of neural tube defect, meaning that a fetus’ developing spine and spinal cord don’t fully form and ...
Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral ...
Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or dose-limiting toxicities at three months Early signals of functional and str ...
Results from Blue Earth Diagnostics’ head-to-head study have been published in the European Journal of Nuclear Medicine and Molecular Imaging and were just presented at the 2026 ASCO Genitourinary ...
Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or dose-limiting toxicities at three months ; Early signal ...
Data support emergence of differentiating clinical benefit with a favorable safety and tolerability profile for patients with ...
Ethnic studies could help California’s youth and teachers learn about — and from — each other. But there’s no state money budgeted for it.
AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC) reported positive topline results from an exploratory Phase 2a trial evaluating its oral R-MDMA candidate, EMP-01, in adults with social anxiety disorder (SAD), ...
California’s AB 2095 could change how employers consider criminal history in hiring. Learn what the proposal means for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results